pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,561 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
autogene cevumeran
Solid Tumor
Genentech Inc
0 catalysts
Phase 2
avenciguat
Systemic Sclerosis (Scleroderma)
Boehringer Ingelheim International GmbH
0 catalysts
Phase 2
avicursen
avicursen [INN]
Relapsing Remitting Multiple Sclerosis (RRMS)
Percheron Therapeutics Ltd
0 catalysts
Phase 2
aviptadil
← prev
page 33 of 53
next →
131
Pain89
Neurology1
Acute Respiratory Distress Syndrome
Adrenergic receptor alpha
$RLFTYMindMaze Therapeutics Holding SA
0 catalysts
Phase 2
avoplacel
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
$PLURPluri Inc.
0 catalysts
Phase 2
axelopran
Opioid-Induced Constipation (OIC)
Mu-type opioid receptor
$TBPHTheravance Biopharma, Inc.
0 catalysts
Phase 2
azacitidine
Vidaza (azacitidine)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
DNA (cytosine-5)-methyltransferase 1DNA (cytosine-5)-methyltransferase 3A
Bristol-Myers Squibb Co
0 catalysts
Phase 2
azenosertib
azenosertib [INN]
Endometrial Cancer
$ZNTLZentalis Pharmaceuticals, Inc.
0 catalysts
Phase 2
azerutamig
azerutamig [INN]
Esophageal Cancer
Bristol-Myers Squibb Co
0 catalysts
Phase 2
bafisontamab
Bile Duct Cancer (Cholangiocarcinoma)
Epidermal growth factor receptorHepatocyte growth factor receptor
EpimAb Biotherapeutics Inc
0 catalysts
Phase 2
balstilimab
Metastatic Colorectal Cancer
Programmed cell death protein 1
$AGENAGENUS INC
0 catalysts
Phase 2
batoclimab
batoclimab [INN]
Graves Diseases
$IMVTImmunovant, Inc.
0 catalysts
Phase 2
beclomethasone dipropionate
Beclomethasone Dipropionate (beclomethasone dipropionate)
Crohn's Disease (Regional Enteritis)
Glucocorticoid receptor
$SNGXSOLIGENIX, INC.
0 catalysts
Phase 2
bedoradrine sulfate
Asthma
Beta-2 adrenergic receptor
$MNOVMEDICINOVA INC
0 catalysts
Phase 2
befiradol
befiradol [INN]
Drug-Induced Dyskinesia
Neurolixis Inc
0 catalysts
Phase 2
belacabnagene franleucel
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis)
$NKTXNkarta, Inc.
0 catalysts
Phase 2
bemcentinib
Non-Small Cell Lung Cancer
Tyrosine-protein kinase receptor UFO
Oncoinvent ASA
0 catalysts
Phase 2
bempikibart
Alopecia Areata
$QTTBQ32 Bio Inc.
0 catalysts
Phase 2
benserazide hydrochloride
Beta Thalassaemia
Aromatic-L-amino-acid decarboxylase
Phoenicia Biosciences Inc
0 catalysts
Phase 2
benzalkonium chloride + polyhexanide
benzalkonium chloride [INN] + polyhexanide [INN]
Onychomycosis (Tinea Unguium)
$TTRXTurn Therapeutics Inc.
0 catalysts
Phase 2
beperminogene perplasmid
Collategene (beperminogene perplasmid [INN])
Arteriosclerosis
AnGes Inc
0 catalysts
Phase 2
bepranemab
Alzheimer's Disease
Microtubule-associated protein tau
UCB SA
0 catalysts
Phase 2
berberine ursodeoxycholate
Primary Sclerosing Cholangitis
HighTide Therapeutics Inc
0 catalysts
Phase 2
beroterkib
Solid Tumor
$MOSMOSAIC CO
0 catalysts
Phase 2
bersiporocin
Idiopathic Pulmonary Fibrosis
Daewoong Pharmaceutical Co Ltd
0 catalysts
Phase 2
betahistine dihydrochloride
Vertigo
$CYTOFAltamira Therapeutics Ltd.
0 catalysts
Phase 2
betamethasone
Keratoconjunctivitis Sicca (Dry Eye)
Glucocorticoid receptor
Surface Ophthalmics Inc
0 catalysts
Phase 2
bexmarilimab
Clevegen (bexmarilimab [INN])
Refractory Acute Myeloid Leukemia
Faron Pharmaceuticals Oy
0 catalysts
Phase 2
bexotegrast
Primary Sclerosing Cholangitis
$PLRXPLIANT THERAPEUTICS, INC.
0 catalysts
Phase 2
bintrafusp alfa
Bile Duct Cancer (Cholangiocarcinoma)
Programmed cell death 1 ligand 1Transforming growth factor beta
Merck KGaA
0 catalysts